The Foot & Ankle Consolidation Trend Continues

May 19, 2022

1 min read

On May 4, CONMED Corporation (NYSE: CNMD) announced a definitive agreement to acquire privately-held In2Bones Global, Inc. for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period.

In2Bone, led by foot and ankle veteran Alan Taylor, had 2021 revenue of $36.8 million with sustained double-digit growth. While CONMED is a large company, including 3,500 employees, it has a small footprint in foot and ankle, making this a partnership an upside on both sides.

Recent Posts

See All

A New Look at Fifth Metatarsal Base Fractures

Fifth metatarsal fractures are traditionally divided into three zones: Zone I (tuberosity avulsions), Zone II (Jones fractures) and Zone III (diaphyseal stress fractures). Based on a recent diagnosti

Surgical Treatment of Insertional Achilles Tendinopathy: An Open Surgeon's Crisis of Faith

by Vince Vacketta, DPM My Gospel: Open debridement of diseased tendon, resection of the osseous deformity, and reanchoring of the Achilles with tendon transfer when needed. The heterodoxy More dev

Is it an Ortho Foot and Ankle Problem, or a Problem of Fellowships in General?

From 2012 to 2023, overall U.S. applicants to American Orthopaedic Foot & Anke Society fellowship slots declined, with the steepest drop among male MD applicants; female applicants remained stable. In

Comments